Marker Therapeutics MRKR

$ 3.09 4.71%

Quarterly report 2024-Q3
added 11-14-2024

Marker Therapeutics Cash and Cash Equivalents 2011-2024 | MRKR

Annual Cash and Cash Equivalents Marker Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
11.8 M	42.4 M	21.4 M	43.9 M	61.7 M	5.13 M	7.85 M	6.58 M	142 K	48.6 K	33.8 K	250 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
61.7 M	33.8 K	16.8 M

Quarterly Cash and Cash Equivalents Marker Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
9 M	7.8 M	11.3 M	15.1 M	17.5 M	18.1 M	6.4 M	11.8 M	18.1 M	25.8 M	28.8 M	42.4 M	48.7 M	57.2 M	64.5 M	21.4 M	21.4 M	21.4 M	21.4 M	43.9 M	43.9 M	43.9 M	43.9 M	61.7 M	61.7 M	61.7 M	61.7 M	5.13 M	5.13 M	5.13 M	5.13 M	7.85 M	7.85 M	7.85 M	7.85 M	6.58 M	6.58 M	6.58 M	6.58 M	142 K	614 K	142 K	142 K	48.6 K	48.6 K	48.6 K	48.6 K	33.8 K	33.8 K	33.8 K	33.8 K	250 K	250 K	250 K	250 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
64.5 M	33.8 K	17.7 M